Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment
暂无分享,去创建一个
B Bioulac | P Burbaud | A Benazzouz | A. Benazzouz | B. Bioulac | P. Burbaud | T. Boraud | J. Féger | C. Gross | J Féger | T Boraud | C Gross
[1] I. Mitchell,et al. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 1987, Journal of the Neurological Sciences.
[2] M. Delong,et al. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. , 1992, Journal of neurophysiology.
[3] P. Robledo,et al. The Subthalamic Nucleus: New Data, New Questions , 1991 .
[4] H. Bergman,et al. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.
[5] C. Hammond,et al. Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus Luysii , 1979, Brain Research.
[6] M R DeLong,et al. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. , 1992, Journal of neurophysiology.
[7] F. W. Cody,et al. Relationship between electromyographic activity and clinically assessed rigidity studied at the wrist joint in Parkinson's disease. , 1992, Brain : a journal of neurology.
[8] C. Marescaux,et al. Contralateral disappearance of parkinsonian signs after subthalamic hematoma , 1992, Neurology.
[9] B Bioulac,et al. Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys , 1993, The European journal of neuroscience.
[10] T. Aziz,et al. Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate , 1991, Movement disorders : official journal of the Movement Disorder Society.
[11] J. Brotchie,et al. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate , 1991, Movement disorders : official journal of the Movement Disorder Society.
[12] A. Benabid,et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.
[13] A. Benabid,et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus , 1991, The Lancet.
[14] P. Robledo,et al. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data , 1990, Brain Research.
[15] R. Robertson,et al. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism. , 1990, Life sciences.
[16] M. Delong,et al. Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism , 1987 .
[17] R. G. Robertson,et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1989, Neuroscience.